Patients with schizophrenia have a substantially higher risk of all-cause mortality than the general population, with a risk ratio of 2.4. Comorbidities like cardiovascular disease, diabetes, and respiratory illness as well as suicide attempts are associated with increased mortality for schizophrenia patients compared to controls. Preventing and managing metabolic disorders, cardiovascular risks, diabetes, smoking, and obesity through treatment guidelines can help lower mortality risk, but these guidelines remain underutilized for schizophrenia patients. It is important for clinicians to regularly assess schizophrenia patients for suicidal thoughts, depression, medication side effects, and risk factors and utilize medications like clozapine that are approved for suicide prevention when indicated.